Biofrontera

$6.41
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.57 (-8.22%) Today
+$0.01 (+0.16%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Biofrontera and other stocks, options, and ETFs commission-free!

About BFRA

Biofrontera AG operates as a biopharmaceutical company, which engages in the development, sale and distribution of dermatological drugs and medical cosmetics for the care, protection and treatment of the skin. Its products are used for the treatment of chronic, antihistamine refractory urticaria and migraine prophylaxis. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany. The listed name for BFRA is Biofrontera AG American Depositary Shares.

CEO
Hermann Lübbert
Employees
174
Headquarters
Leverkusen, Nordrhein-Westfalen
Founded
1997
Market Cap
159.38M
Price-Earnings Ratio
Dividend Yield
Average Volume
81.53K
High Today
$6.65
Low Today
$6.25
Open Price
$6.61
Volume
625.20K
52 Week High
$55.00
52 Week Low
$5.27

BFRA Earnings

-$0.34
-$0.22
-$0.10
$0.02
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Apr 19

You May Also Like

HDIV
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure